Zedelmayer Christine 4
4 · Equillium, Inc. · Filed Mar 16, 2026
Research Summary
AI-generated summary of this filing
Equillium (EQ) COO Christine Zedelmayer Sells Shares
What Happened
Christine Zedelmayer, Senior Vice President and Chief Operating Officer of Equillium (EQ), exercised stock options for 120,312 shares (code M) and sold the same 120,312 shares in open-market transactions on March 13, 2026. The exercise reported an aggregate cost of $94,445 (exercise price $0.79 per share). The shares were sold at a weighted-average price of $2.50 per share for gross proceeds of $300,816 (prices ranged $2.515–$2.50). The transactions were executed under a Rule 10b5-1 trading plan.
Key Details
- Transaction date: March 13, 2026
- Option exercise: 120,312 shares at $0.79 each; aggregate exercise cost $94,445 (code M)
- Open-market sale: 120,312 shares at weighted-average $2.50; gross proceeds $300,816 (code S)
- Sale executed pursuant to a Rule 10b5-1 plan adopted Aug 27, 2025 (Footnote F1)
- Sale prices ranged $2.515 to $2.50; weighted average shown (Footnote F2)
- Vesting note: option vests 25% after one year, remainder in 36 monthly installments (Footnote F3)
- Shares owned after the transaction: not specified in the Form 4 filing
- Filing date: March 16, 2026 (reporting period: March 13, 2026)
Context
This was an exercise of options followed by an immediate sale of the exercised shares — effectively a cashless exercise where the insider converted options to shares and sold them the same day. The use of a pre-established 10b5-1 plan indicates the sale was scheduled in advance; this is common for insiders to avoid timing questions. The filing is factual and does not by itself indicate insider sentiment beyond the reported transactions.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-03-13$0.79/sh+120,312$94,445→ 182,898 total - Sale
Common Stock
[F1][F2]2026-03-13$2.50/sh−120,312$300,816→ 62,586 total - Exercise/Conversion
Employee Stock Option (right to buy)
[F3]2026-03-13−120,312→ 54,688 totalExercise: $0.79Exp: 2033-01-02→ Common Stock (120,312 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.515 to $2.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.